Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February ...

With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.

Together, Ram and Carrie strengthen Kaléo’s leadership team as the Company continues to support its autoinjector portfolio, advance development programs aligned with emergency preparedness, and ...

The Furoscix on-body infusor. [Image courtesy of MannKind] MannKind (Nasdaq:MNKD) announced today that the FDA approved its Furoscix (furosemide) on-body infusor for pediatric patients. The company ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...

CLEVELAND — Most stadiums and arenas are equipped with safety equipment like fire extinguishers or defibrillator machines. However, one of the biggest arenas in our state – Rocket Arena – is going a ...

Please provide your email address to receive an email when new articles are posted on . Feasibility and acceptability scores for the autoinjector were highest among health care professionals. All ...

MannKind Corporation delivered strong Q3 '25 results, beating EPS and revenue estimates, and shares have responded positively. The FDA accepted the supplemental New Drug Application for the FUROSCIX ...

A Prescription Drug User Fee Act target date of July 26, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application ...

Sempresto, Inc., a medical device company pioneering smartphone-integrated rescue drug delivery, today announced the acquisition of all patents and related physical and digital assets from inventor ...